Estrogen-induced breast cancer: Alterations in breast morphology and oxidative stress as a function of estrogen exposure
Epidemiological evidence indicates that prolonged lifetime exposure to estrogen is associated with elevated breast cancer risk in women. Oxidative stress and estrogen receptor-associated proliferative changes are suggested to play important roles in estrogen-induced breast carcinogenesis. In the present study, we investigated changes in breast morphology and oxidative stress following estrogen exposure. Female ACI rats were treated with 17{beta}-estradiol (E{sub 2}, 3 mg, s.c.) for either 7, 15, 120 or 240 days. Animals were euthanized, tissues were excised, and portions of the tissues were either fixed in 10% buffered formalin or snap-frozen in liquid nitrogen. Paraffin-embedded tissues were examined for histopathologic changes. Proliferative changes appeared in the breast after 7 days of E{sub 2} exposure. Atypical ductal proliferation and significant reduction in stromal fat were observed following 120 days of E{sub 2} exposure. Both in situ and invasive carcinomas were observed in the majority of the mammary glands from rats treated with E{sub 2} for 240 days. Palpable breast tumors were observed in 82% of E{sub 2}-treated rats after 228 days, with the first palpable tumor appearing after 128 days. No morphological changes were observed in the livers, kidneys, lungs or brains of rats treated with E{sub 2} for 240 days compared to controls. Furthermore, 8-isoprostane (8-isoPGF{sub 2{alpha}}) levels as well as the activities of antioxidant enzymes, such as glutathione peroxidase, superoxide dismutase and catalase, were quantified in the breast tissues of rats treated with E{sub 2} for 7, 15, 120 and 240 days and compared to activity levels in age-matched controls. 8-isoPGF{sub 2{alpha}} levels displayed time-dependent increases upon E{sub 2} treatment and were significantly higher than control levels at the 15, 120 and 240 day time-points. 8-isoPGF{sub 2{alpha}} observed in E{sub 2}-induced mammary tumors were significantly higher than levels found in control mammary tissue from age-matched animals. Similarly, alterations in glutathione peroxidase and superoxide dismutase activities were detected in both mammary and tumor tissue from E{sub 2}-treated rats. Taken together, our data reveal that proliferative changes in the breast tissue of ACI rats are associated with increases in 8-isoPGF{sub 2{alpha}} formation as well as changes in the activities of antioxidant enzymes. These oxidative changes appear to be a function of E{sub 2} exposure and occur prior to tumor development.